Category Archives: Life Sciences
Warning: Drug Development May Have Side Effects
Much good comes from the development of pharmaceuticals, biologics and other novel therapeutics. However, as with almost any venture, where there is reward there is the risk of negative side effects.
Continue reading →Who Owns that Gene? Angelina Jolie, BRCA1, and Intellectual Property
Angela Jolie’s news this week highlights the issue of whether human genetic material should be patentable, an issue soon to be decided by the U.S. Supreme Court.
Continue reading →Medical Device and Pharmaceutical Product Recalls – What Role for Insurance?
Anybody who tracks medical device and pharmaceutical FDA recalls knows that these occur with some regularity and that some of the recalls are necessary to prevent serious life threatening injuries. A product recall can be potentially devastating for the product …
Continue reading →Sovereign Immunity: The Medieval Concept With Modern Risks for Science
In the United States, when a drug or medical device company conducts its human clinical trials at a government-owned facility, it may be stepping back in time where indemnification is concerned. This is because state or federal medical facilities fall …
Continue reading →What Risks Will Emerge in 2013?
We look ahead for the risks businesses should prepare for in 2013. Read their predictions and vote for the one most likely to affect your business this year.
Continue reading →Unique to Life Science Companies: Loss of Non-Damaged Property
Life science companies face a unique and significant property loss potential that is not covered by a traditional property insurance policy.
Continue reading →Hidden Risks of Hospital Clinical Research
Hospitals can benefit from conducting clinical research in their facilities, but failure to identify and handle the risk exposures this research creates can cost millions of dollars.
Continue reading →Emerging Life Sciences Risk of 2012
Outside the U.S., many regulators are requiring trial sponsors to compensate clinical trial participants for injuries sustained during participation in a trial.
Continue reading →
